ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,697Medicare Part D Prescriptions Filled, Including Refills

Rank: 165 out of 1383

$625K Total Retail Price of All Prescriptions

Rank: 227 out of 1383

908 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 908 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

26% of this provider’s 908 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 6,389 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 712 219 S3 1 1
AMLODIPINE BESYLATE 676 337 2 6
SIMVASTATIN 588 258 3 2
FUROSEMIDE 403 248 4 7
OMEPRAZOLE 338 224 5 5
METFORMIN HCL 306 125 6 8
LISINOPRIL 306 130 6 3
CARVEDILOL 296 132 8 24
LEVOTHYROXINE SODIUM 245 143 9 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 235 65 10 27
FLUTICASONE PROPIONATE 225 85 11 39
HYDROCHLOROTHIAZIDE 220 75 12 10
METOPROLOL TARTRATE 193 105 13 9
RANITIDINE HCL 191 96 14 19
CLONIDINE HCL 191 58 14 44
POTASSIUM CHLORIDE 181 125 16 12
GABAPENTIN 175 89 17 11
WARFARIN SODIUM 147 85 18 13
HYDRALAZINE HCL 138 63 19 86
PROAIR HFA 138 57 19 42
ZOLPIDEM TARTRATE 134 45 21 17
MELOXICAM 134 68 21 20
GLIMEPIRIDE 120 77 23 31
AZITHROMYCIN 116 34 24 41
BENAZEPRIL HCL 115 91 25 38
LANTUS 106 44 26 50
ALLOPURINOL 106 65 26 33
AMITRIPTYLINE HCL 105 0 R 28 57
PLAVIX 101 83 29 43
CYCLOBENZAPRINE HCL 100 24 R 30 69
TRAMADOL HCL 95 27 31 25
PRAVASTATIN SODIUM 95 82 31 14
TRAZODONE HCL 92 52 33 36
PREDNISONE 91 34 34 40
PROMETHAZINE HCL 88 0 R 35 56
DIGOXIN 88 62 35 59
POLYETHYLENE GLYCOL 3350 87 31 37 64
KLOR-CON 10 86 38 38 74
NEXIUM 84 23 39 26
CITALOPRAM HBR 83 59 40 15
FENTANYL 79 29 S2 41 92
CLOPIDOGREL 78 65 42 28
DONEPEZIL HCL 77 67 43 35
INSULIN SYRINGE 74 22 44 83
TRIAMTERENE-HCTZ 74 24 44 48
TAMSULOSIN HCL 71 40 46 30
GLIPIZIDE 69 46 47 98
RISPERIDONE 66 39 48 71
MORPHINE SULFATE ER 66 0 S2 48 77
FLUCONAZOLE 66 11 48 136
JANUVIA 64 27 51 85
BACLOFEN 63 15 52 118
OXYCODONE HCL-ACETAMINOPHEN 62 26 S2 53 81
CEPHALEXIN 62 23 53 87
SERTRALINE HCL 60 18 55 21
LANTUS SOLOSTAR 60 39 55 112
OXYCODONE-ACETAMINOPHEN 59 31 S2 57 107
NAPROXEN 58 19 58 105
CRESTOR 55 29 59 34
METOPROLOL SUCCINATE 55 37 59 29
GLYBURIDE 55 39 R 59 46
NOVOLOG 54 0 62 139
LOSARTAN POTASSIUM 53 22 63 23
DIVALPROEX SODIUM 53 13 63 78
DILTIAZEM ER 51 26 65 110
QUETIAPINE FUMARATE 50 20 66 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.